Back to Search Start Over

Maintenance therapy for advanced non‐small cell lung cancer (NSCLC)

Maintenance therapy for advanced non‐small cell lung cancer (NSCLC)

Authors :
Sophie Paget-Bailly
Ludovic Trinquart
Maurice Pérol
Héloïse Pana-Katatali
François Calais
Virginie Westeel
Franck Bonnetain
David Pérol
Valérie Paulus
Source :
Cochrane Database Syst Rev, The Cochrane Library
Publication Year :
2015
Publisher :
John Wiley & Sons, Ltd, 2015.

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: In patients with advanced NSCLC: to establish clinical effectiveness, in terms of overall survival (OS) and progression free survival and (PFS), of maintenance therapy compared with placebo or observation, which is considered as standard of care; to compare clinical effectiveness, in terms of OS and PFS, of different agents or combinations in the maintenance setting (i.e. chemotherapy vs targeted agent, chemotherapy plus targeted agent vs chemotherapy or targeted agent), and to assess the toxicity of maintenance therapy.

Details

Language :
English
Database :
OpenAIRE
Journal :
Cochrane Database Syst Rev, The Cochrane Library
Accession number :
edsair.doi.dedup.....f8497e415f8f0c4fe992e2147ac99b7b